Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Review of Clinical Immunology|March 13, 2024
How to and should we target EBV in MS?Svetlana Eckert, Dejan Jakimovski, Robert Zivadinov, et al.Expert Opinion on Drug Safety|August 4, 2020
Long-term drug treatment in multiple sclerosis: safety success and concernsDejan Jakimovski, Caila B Vaughn, Svetlana Eckert, et al.Multiple Sclerosis and Related Disorders|September 30, 2018
Stress-full life events and multiple sclerosis: A population-based incident case-control studyIbrahim Abdollahpour, Saharnaz Nedjat, Mohammad Ali Mansournia, et al.Journal of Neurology|April 6, 2026
Dura mater enhancement on 3T MRI is associated with cortical lesion burden in multiple sclerosisRobert Zivadinov, Mehak Semy, Alexander Bartnik, et al.Multiple Sclerosis and Related Disorders|December 10, 2020
Late onset multiple sclerosis is associated with more severe ventricle expansionDejan Jakimovski, Dora Dujmic, Jesper Hagemeier, et al.Multiple Sclerosis and Related Disorders|December 17, 2020
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosisFranziska E Hildesheim, Deepa P Ramasamy, Niels Bergsland, et al.Annals of Clinical and Translational Neurology|November 18, 2024
Determinants of long-term paramagnetic rim lesion evolution in people with multiple sclerosisJack A Reeves, Alexander Bartnik, Maryam Mohebbi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2020
Recovery of cognitive function after relapse in multiple sclerosisRalph Hb Benedict, Jeta Pol, Faizan Yasin, et al.Journal of Neurology|June 3, 2026
Ultra-low-field MRI for bedside imaging of severe multiple sclerosisNiels Bergsland, Alex Burnham, Michael G Dwyer, et al.Journal of Neurology|November 15, 2022
Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectivesPenny Pennington, Bianca Weinstock-Guttman, Channa Kolb, et al.Pageof 2